Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E M Toes

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Molecular Pharmaceutics|October 20, 2023
Effect of Antigen Valency on Autoreactive B-Cell TargetingM J van Weijsten, K R Venrooij, L P W M Lelieveldt, et al.
Annals of the Rheumatic Diseases|April 15, 2005
Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltrationR J Verburg, R Flierman, J K Sont, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10T C A Tolboom, E Pieterman, W H van der Laan, et al.
Rheumatology (Oxford, England)|March 8, 2007
Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patientsA L Feitsma, R E M Toes, A B Begovich, et al.
Arthritis Research & Therapy|December 8, 2021
Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modificationsM Volkov, A S B Kampstra, K A van Schie, et al.
Gene Therapy|October 21, 2003
Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1M Ossevoort, B M J Visser, D J M van den Wollenberg, et al.
Genes and Immunity|December 18, 2015
A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levelsT C Messemaker, M Frank-Bertoncelj, R B Marques, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy ControlsH Koppejan, L A Trouw, J Sokolove, et al.
Annals of the Rheumatic Diseases|May 14, 2014
Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodiesJ Suurmond, F Rivellese, A L Dorjée, et al.
Annals of the Rheumatic Diseases|May 20, 2009
Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritisL Damjanovska, M M Thabet, E W N Levarth, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Molecular Pharmaceutics|October 20, 2023
Effect of Antigen Valency on Autoreactive B-Cell TargetingM J van Weijsten, K R Venrooij, L P W M Lelieveldt, et al.
Annals of the Rheumatic Diseases|April 15, 2005
Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltrationR J Verburg, R Flierman, J K Sont, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10T C A Tolboom, E Pieterman, W H van der Laan, et al.
Rheumatology (Oxford, England)|March 8, 2007
Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patientsA L Feitsma, R E M Toes, A B Begovich, et al.
Arthritis Research & Therapy|December 8, 2021
Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modificationsM Volkov, A S B Kampstra, K A van Schie, et al.
Gene Therapy|October 21, 2003
Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1M Ossevoort, B M J Visser, D J M van den Wollenberg, et al.
Genes and Immunity|December 18, 2015
A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levelsT C Messemaker, M Frank-Bertoncelj, R B Marques, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy ControlsH Koppejan, L A Trouw, J Sokolove, et al.
Annals of the Rheumatic Diseases|May 14, 2014
Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodiesJ Suurmond, F Rivellese, A L Dorjée, et al.
Annals of the Rheumatic Diseases|May 20, 2009
Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritisL Damjanovska, M M Thabet, E W N Levarth, et al.
Pageof 7